Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Free Cash Flow (2020 - 2025)

BioAtla's Free Cash Flow history spans 6 years, with the latest figure at -$7.9 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 52.84% year-over-year to -$7.9 million; the TTM value through Dec 2025 reached -$48.2 million, up 32.99%, while the annual FY2025 figure was -$48.2 million, 32.99% up from the prior year.
  • Free Cash Flow reached -$7.9 million in Q4 2025 per BCAB's latest filing, up from -$9.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$5.1 million in Q3 2024 to a low of -$30.8 million in Q1 2024.
  • Average Free Cash Flow over 5 years is -$18.9 million, with a median of -$18.1 million recorded in 2022.
  • Peak YoY movement for Free Cash Flow: crashed 353.0% in 2021, then surged 81.25% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$21.9 million in 2021, then dropped by 11.35% to -$24.3 million in 2022, then decreased by 22.93% to -$29.9 million in 2023, then soared by 43.93% to -$16.8 million in 2024, then soared by 52.84% to -$7.9 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Free Cash Flow are -$7.9 million (Q4 2025), -$9.9 million (Q3 2025), and -$14.1 million (Q2 2025).